Verified email at - Homepage
Cited by
Cited by
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report …
JJM Van Dongen, AW Langerak, M Brüggemann, PAS Evans, M Hummel, ...
Leukemia 17 (12), 2257-2317, 2003
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide …
MV Mateos, A Oriol, J Martínez-López, N Gutiérrez, AI Teruel, R de Paz, ...
The lancet oncology 11 (10), 934-941, 2010
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study
MV Mateos, JM Hernández, MT Hernández, NC Gutiérrez, L Palomera, ...
Blood 108 (7), 2165-2172, 2006
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis …
E Pérez-Persona, MB Vidriales, G Mateo, R García-Sanz, MV Mateos, ...
Blood, The Journal of the American Society of Hematology 110 (7), 2586-2592, 2007
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ...
Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
J Martinez-Lopez, JJ Lahuerta, F Pepin, M González, S Barrio, R Ayala, ...
Blood 123 (20), 3073-3079, 2014
International prognostic scoring system for Waldenström macroglobulinemia
P Morel, A Duhamel, P Gobbi, MA Dimopoulos, MV Dhodapkar, J McCoy, ...
Blood 113 (18), 4163-4170, 2009
International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease
E Terpos, G Morgan, MA Dimopoulos, MT Drake, S Lentzsch, N Raje, ...
Journal of clinical oncology 31 (18), 2347, 2013
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
AW Langerak, PJTA Groenen, M Brüggemann, K Beldjord, C Bellan, ...
Leukemia 26 (10), 2159-2171, 2012
Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis
J Sunyer, J Schwartz, A Tobías, D Macfarlane, J Garcia, JM Antó
American journal of epidemiology 151 (1), 50-56, 2000
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and …
M Ocqueteau, A Orfao, J Almeida, J Blade, M Gonzalez, R García-Sanz, ...
The American journal of pathology 152 (6), 1655, 1998
Improved reliability of lymphoma diagnostics via PCR-based clonality testing:—Report of the BIOMED-2 concerted action BHM4-CT98-3936
J Van Krieken, AW Langerak, EA Macintyre, M Kneba, E Hodges, ...
Leukemia 21 (2), 201-206, 2007
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ...
Leukemia 31 (10), 2094-2103, 2017
Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases
R García‐Sanz, S Montoto, A Torrequebrada, AG De Coca, J Petit, ...
British journal of haematology 115 (3), 575-582, 2001
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, PI Croucher, R García-Sanz, M Boccadoro, ...
Annals of Oncology 20 (8), 1303-1317, 2009
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
M Brüggemann, H White, P Gaulard, R Garcia-Sanz, P Gameiro, ...
Leukemia 21 (2), 215-221, 2007
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism …
ME Sarasquete, R Garcia-Sanz, L Marin, M Alcoceba, MC Chillón, ...
Blood 112 (7), 2709-2712, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom’s Macroglobulinemia
MA Dimopoulos, MA Gertz, E Kastritis, R Garcia-Sanz, EK Kimby, ...
J Clin Oncol 27 (1), 120-6, 2009
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
BA Walker, CP Wardell, L Melchor, A Brioli, DC Johnson, MF Kaiser, ...
Leukemia 28 (2), 384-390, 2014
The system can't perform the operation now. Try again later.
Articles 1–20